Status:
COMPLETED
Risk Prediction and Its Intelligent Assessment for Cognitive Impairment Among Community-dwelling Older Adults
Lead Sponsor:
Peking University Sixth Hospital
Conditions:
Cognitive Impairment
Predictive Model
Eligibility:
All Genders
65+ years
Brief Summary
Cognitive impairment is one of the core early signs of dementia, and it is also a key stage for community-based dementia prevention. Accurate and convenient prediction of cognitive impairment can help...
Eligibility Criteria
Inclusion
- Aged 65 or over at baseline;
- With normal cognitive function at baseline (score ≥ 18 on the Chinese version of Mini-Mental State Examination, MMSE);
- Completed MMSE assessment three years later;
- Provided informed consent voluntarily.
Exclusion
- Aged \<65;
- had a history of dementia or MMSE score \< 18 at baseline;
- lost to follow-up or without cognitive function assessment three years later;
- Refused to participate the survey.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2023
Estimated Enrollment :
13228 Patients enrolled
Trial Details
Trial ID
NCT05385874
Start Date
April 1 2022
End Date
December 30 2023
Last Update
April 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Six Hospital
Beijing, China, 100191